Fischer Medical Ventures (BOM:524743) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


BOM:524743 Fischer Medical Ventures Ltd BOM:524743
40 GF Score
Price ₹39.31
GF Value ₹217.96
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Fischer Medical Ventures Research & Development?

Fischer Medical Ventures BOM:524743 +0.59% 40 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:524743 with a GF Score™ of 40/100 and a GF Value™ of ₹217.96 (Possible Value Trap). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fischer Medical Ventures's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Fischer Medical Ventures  (BOM:524743) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fischer Medical Ventures Research & Development Related Terms

Fischer Medical Ventures Research & Development Historical Data

* Premium members only.

The historical data trend for Fischer Medical Ventures's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fischer Medical Ventures Research & Development Chart

Fischer Medical Ventures Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fischer Medical Ventures Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:524743
40GF Score
Fischer Medical Ventures Ltd BOM:524743
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fischer Medical Ventures Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Fischer Medical Ventures (BOM:524743) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Fischer Medical Ventures and its competitors.
Is Fischer Medical Ventures' Research & Development too high?
Fischer Medical Ventures' current Research & Development is ₹0 Mil. Overall, Fischer Medical Ventures has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fischer Medical Ventures' Research & Development compare to ABT and SYK?
Fischer Medical Ventures' Research & Development of ₹0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fischer Medical Ventures and its competitors. Fischer Medical Ventures's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fischer Medical Ventures stock overvalued right now?
Based on GuruFocus' analysis, Fischer Medical Ventures (BOM:524743) is currently considered Possible Value Trap. The stock's GF Value™ is ₹217.96, compared to a current price of ₹39.31 — trading 82% below its estimated fair value. The current Research & Development is ₹0 Mil. Fischer Medical Ventures' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fischer Medical Ventures (BOM:524743), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fischer Medical Ventures (BOM:524743) Overvalued in 2026?

Based on GuruFocus' analysis, Fischer Medical Ventures stock appears to be undervalued. The current stock price of ₹39.31 is trading 82% below its estimated GF Value™ of ₹217.96. GuruFocus considers Fischer Medical Ventures to be Possible Value Trap.

Key valuation signals for BOM:524743:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹217.96 vs. price of ₹39.31 (82% below fair value)
  • GF Score™: 40/100 with 3 warning signs

No single metric tells the full story. See the BOM:524743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fischer Medical Ventures Business Description

Other Exchanges FISCHER:India
Address No. 129-140, Greams Road, Level 5, Prestige Palladium Bayan, Chennai, TN, IND, 600006
Fischer Medical Ventures Ltd is engaged in developing and trading of Medical Equipment including cutting-edge Magnetic Resonance Imaging (MRI) systems in India.
40GF Score

Get the complete analysis for BOM:524743

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹39.31
Price
₹217.96
GF Value